SCHEMBL356492

SCHEMBL356492

Brc1ccccc1-c1nc2ccccc2n1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.62
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
ESR2 Q92731 5/20 0.54
ESR1 P03372 4/20 0.54
RAB9A P51151 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
PRKACA P17612 1/20 0.50
RPS6KB1 P23443 1/20 0.50
GSK3B P49841 1/20 0.50
ROCK1 Q13464 1/20 0.50
PDE10A Q9Y233 1/20 0.46
GSR P00390 1/20 0.46
GRIA1 P42261 1/20 0.43
CACNG8 Q8WXS5 1/20 0.43
CACNG2 Q9Y698 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29521808 1.00 RECQL (0.62) RECQLMAPK1HTTESR2ESR1
SCHEMBL13085156 0.88 RECQL (0.71) RECQLMAPK1HTTESR2ESR1
SCHEMBL29466050 0.88 RECQL (0.57) RECQLMAPK1HTTESR2ESR1
SCHEMBL28695006 0.88 RECQL (0.57) RECQLMAPK1HTTESR2ESR1
SCHEMBL12854005 0.86 RECQL (0.69) RECQLMAPK1HTTESR2ESR1
SCHEMBL3473850 0.86 RECQL (0.69) RECQLMAPK1HTTESR2ESR1
SCHEMBL15770226 0.86 ESR1 (0.55) RECQLMAPK1HTTESR2ESR1
SCHEMBL28713083 0.84 ESR1 (0.53) RECQLMAPK1HTTESR2ESR1
SCHEMBL22522284 0.82 RECQL (0.64) RECQLMAPK1HTTESR2ESR1
SCHEMBL647306 0.82 RECQL (0.64) RECQLMAPK1HTTESR2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103524497-B Bipolarity phosphorescence host compound, preparation method and application and electroluminescent device TCL GROUP CO., LTD. (CN) 2015-08-05 CN claimed
CN-109776335-B Amine derivative of pyrene, preparation method, application and device thereof 武汉尚赛光电科技有限公司 2022-03-18 CN disclosed
EP-2477979-B1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORP (JP) 2016-10-26 EP disclosed
EP-2477979-B1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORP (JP) 2016-10-26 EP disclosed
CN-103524497-B Bipolarity phosphorescence host compound, preparation method and application and electroluminescent device TCL GROUP CO., LTD. (CN) 2015-08-05 CN disclosed
US-8808879-B2 Phototherapy devices and methods comprising substituted carbazole compounds NITTO DENKO CORPORATION (JP) 2014-08-19 US disclosed
US-8808879-B2 Phototherapy devices and methods comprising substituted carbazole compounds NITTO DENKO CORPORATION (JP) 2014-08-19 US disclosed
US-8808879-B2 Phototherapy devices and methods comprising substituted carbazole compounds NITTO DENKO CORPORATION (JP) 2014-08-19 US disclosed
US-8586205-B2 Compounds for organic light emitting diode emissive layers NITTO DENKO CORPORATION (JP) 2013-11-19 US disclosed
US-8586205-B2 Compounds for organic light emitting diode emissive layers NITTO DENKO CORPORATION (JP) 2013-11-19 US disclosed
WO-2012012295-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-26 WO disclosed
WO-2012012295-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-26 WO disclosed
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-19 US disclosed
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-19 US disclosed
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-01-19 US disclosed
WO-2011034967-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-24 WO disclosed
WO-2011034967-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-24 WO disclosed
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-17 US disclosed
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-17 US disclosed
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS NITTO DENKO CORPORATION (JP) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016449-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING SUBSTITUTED CARBAZOLE COMPOUNDS TYR, PPOX, CRY1 RECQL 683/4885MAPK1 1889/4885HTT 1661/4885
US-20110062386-A1 COMPOUNDS FOR ORGANIC LIGHT EMITTING DIODE EMISSIVE LAYERS ALOX12, ALOX15B, ALOX15 RECQL 988/4885MAPK1 687/4885HTT 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.